In the liver of patients with DM2, TRB3 expression is increased independent of nutrients’ excess or hyperinsulinemia, leading to defects in insulin signaling and triggering a reduction in glycogen synthesis that is mediated by insulin as well as an increase in gluconeogenesis, which leads to hyperglycemia [28, 33, 34]. This evidence concerns the gene INS and hyperinsulinism.